The global Nebulizer market size is projected to reach USD 1,778.8 million by 2027, exhibiting a CAGR of 8.1% during the forecast period. Increasing prevalence of respiratory disorders around the world will be the prime growth propeller for this market, shares Fortune Business Insights™ in its new report, titled “Nebulizer Market Size, Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027”.
The World Health Organization (WHO) states that respiratory diseases are the foremost cause of death and disability worldwide. According to its estimates, chronic obstructive pulmonary disorder (COPD) afflicts around 65 million and kills 3 million people every year. Similarly, pneumonia also kills millions of people annually and is the leading cause of mortality among children under 5 years of age. Furthermore, WHO data indicates that lung cancer is the deadliest cancer, killing 1.6 million people every year. Nebulizer play a key role in managing these chronic and potentially fatal lung disorders and as the incidence of these disorders grows, the demand for Nebulizer will continue to surge.
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/nebulizers-market-100707
OMRON Healthcare and AAFA Collaborate to Offer Better Respiratory Medical Care to Underserved Societies
OMRON Healthcare, Inc., who is a global trendsetter in respiratory health technologies with over 40 years of headship in the medical device classification, is working co-jointly with the Asthma and Allergy Foundation of America (AAFA), which is the foremost patient organization for people dealing with asthma and allergies to lift admission to prescription-grade respiratory technologies. Moreover, OMRON’s backing is also likely to aid AAFA in supplying educational material to communities in most need of such resources.
OMRON is donating a variety of its medical-grade nebulizers, which AAFA will apply for crucial advocacy and education initiatives that assist the most susceptible people in the asthma community.
Rising Demand for Home Healthcare Devices to Surge Demand for Nebulizers
The increasing prices of healthcare services and hospital stays have resulted in an inclination of the patient towards getting home treatment, thereby surging the implementation of breathable medical devices for home healthcare. Furthermore, the rising demand for effectual inhaled drug delivery devices and the campaigning of respiratory care devices for home use by several healthcare organizations are probable to drive the Nebulizer market growth during the forecast period.
The report states that the market value was at USD 909.7 million in 2019. Its other highlights include:
- Valuable insights into the key market drivers, trends, and restraints;
- Exhaustive analysis of the upcoming market opportunities;
- In-depth examination of the impact of the COVID-19 outbreak on the market; and
- Comprehensive study of the regional prospects and competitive dynamics influencing the market.
Rapid Transmission of the COVID-19 Infection to Create Immediate Growth Opportunities
The SARS-CoV-2 infection attacks the respiratory tract and lungs, causing shortness of breath, acute breathing problems, and pneumonia, along with a persistent fever and cough. People with preexisting lung disorders such as asthma are at high risk of contracting the COVID-19 infection. According to the Centers for Disease Control and Prevention (CDC), asthma patients are highly recommended to carry inhalers or portable Nebulizer with them as these devices can efficiently open the lungs and allow them to function normally. In this scenario, the uptake of inhalable drug delivery devices is likely to spike and favor the Nebulizer market growth. The only worry with these devices, as pointed out by the Asthma and Allergy Foundation of America, is their potential to transmit the infection among patients as well as healthcare workers, especially in healthcare facilities. If this issue is addressed, players can capitalize on the current pandemic and expand their presence in the market.
Speak To Our Analyst:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Related Reports :
USD 49.46 Billion Global Biobanking Market During 2021-2028 | Fortune Business Insights
USD 10.04 Billion Global Clear Aligners Market During 2021-2028 | Fortune Business Insights
USD 11.40 Billion Global COVID-19 Diagnostics Market During 2021-2028 | Fortune Business Insights
USD 9.64 Billion Global CT Scanners Market During 2021-2028 | Fortune Business Insights
USD 16.07 Billion Global Dental Equipment Market During 2021-2028 | Fortune Business Insights
Eyewear Market In United States | Fortune Business Insights